Grind, a portable basketball training machine, was started by Thomas Fields in 2020. As of September 2023, Grind’s net worth is $2 Million, and as for sales increase or decrease in 2023, there is no data available to determine this.
On May 7, 2021, they appeared on Season 12 of Shark Tank USA and made a deal with Mark Cuban and Barbara Corcoran, $250,000 for 25% equity. The final valuation was $1 Million, down from the founder’s initial estimate of $5 Million.
Grind is still in business. Their website is still active and promoting their product.
Grind Net Worth
| Net worth | $2 Million (2023) |
| Annual Sales Revenue | $1 million (2021) |
| Profits | – |
| Lifetime sales | – |
| Investors | Mark Cuban and Barbara Corcoran |
| Founder | Thomas Fields |
| Employees | – |
Grind Net Worth Timeline
| Net Worth 2023 | $2 Million |
| Net Worth 2022 | $1.3 Million |
| Net Worth 2021 | $1 Million |
| Net Worth 2020 | $800,000 |
| Net worth valuation 2021 after appearing on Shark Tank | $1 Million |
| Net worth valuation 2021 before appearing on Shark Tank | $5 Million |
Grind Pitch on Shark Tank
| Company name | Grind |
| Product | portable basketball training machine |
| Episode | Season 12 Episode 23 |
| Founder | Thomas Fields |
| Asked for | $250,000 for 5% equity |
| Final deal | $250,000 for 25% equity |
| Sharks | Mark Cuban and Barbara Corcoran |
| Location | USA |
Grind Founder
Grind was founded by Thomas Fields in 2020. Fields was a high school basketball star. He created the world’s first portable basketball shooting machine. Grind’s founder, Thomas Fields, has a net worth of 1 million USD as of 2023.
Key accomplishments
| Year | Accomplishment |
| 2020 | Grind developed the world’s first portable shooting and rebounding machine |
| 2021 | Grind appeared on Shark Tank Season 12 |
Conclusion
From their beginnings on Shark Tank to their current status as a thriving business. They have proven that with the right idea and execution, anything is possible. We can’t wait to see the future for Grind and its continued success.